SANGAMO BIOSCIENCES, INC. (NASDAQ: SGMO) has filed to raise capital. The company filed with the SEC on Wednesday night to raise up to $100 million with the sale of any combination of the following securities: Common Stock; Preferred Stock; Debt Securities; Warrants to Purchase Common Stock; and/or Warrants to Purchase Preferred Stock.
This was a shelf filing so no underwriters were named. The use of proceeds is listed as the traditional “general corporate purposes” and that includes “support for continuing research and development, commercialization activities, business development activities, and potential acquisitions of businesses, products, technologies or licenses that are complementary to Sangamo’s business.
The company did specify that it has no current plans, commitments or agreements with respect to any acquisitions.
Before the effects of any offering, Yahoo! Finance noted a market capitalization rate of $297.5 million. At $5.67, the 52-week trading range is $2.36 to $9.15 and the average daily trading volume is roughly 385,000 shares.
Sponsored: Want to Retire Early? Here’s a Great First Step
Want retirement to come a few years earlier than you’d planned? Orare you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
